FDA Person
FDAMargaret M. Annes
View detailed information about Margaret M. Annes, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 73 inspections of 64 companies, 2016–2026.
Inspections (73)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 25, 2026 | B. Braun US Pharmaceutical Manufacturing LLC | Not classified | Drug Quality Assurance | #1334920 |
| August 28, 2026 | Houston Rx LLC | Not classified | Drug Quality Assurance | #1324528 |
| July 31, 2026 | Allergan Sales, LLC | Not classified | Drug Quality Assurance | #1316492 |
| June 17, 2026 | Cytovance Biologics Inc. | Not classified | #1322570 | |
| June 3, 2026 | Veterinary Enterprises of Tomorrow Inc. | Not classified | Drug Quality Assurance | #1300344 |
| March 20, 2026 | Eosera, Inc. | Not classified | Drug Quality Assurance | #1308346 |
| March 6, 2026 | AURORIUM LLC | Not classified | #1306572 | |
| December 11, 2025 | Denver Solutions, LLC DBA Leiters Health | Not classified | Drug Quality Assurance | #1294820 |
| October 31, 2025 | BioMed Laboratories, LLC. | OAI | Drug Quality Assurance | #1291300 |
| September 18, 2025 | Petscript Inc. | Not classified | Monitoring of Marketed Animal Drugs, Feeds, and Devices | #1268183 |
| August 28, 2025 | RC Outsourcing, LLC | OAI | Drug Quality Assurance | #1279818 |
| June 26, 2025 | Dhaliwal Laboratories LLC | Not classified | #1274979 | |
| June 13, 2025 | 3D Imaging Drug Design and Development | OAI | Drug Quality Assurance | #1272748 |
| May 12, 2025 | Sovereign Pharmaceuticals, LLC | Not classified | Drug Quality Assurance | #1263602 |
| March 5, 2025 | Compounders International Analytical Laboratory | OAI | Drug Quality Assurance | #1263374 |
| February 14, 2025 | Deepwater Chemicals, Inc | Not classified | #1251231 | |
| December 4, 2024 | Kansas Analytical Services LLC | NAI | Drug Quality Assurance | #1259077 |
| November 22, 2024 | Magnesium Products, Inc. | Not classified | #1254970 | |
| September 27, 2024 | OurPharma LLC | VAI | Drug Quality Assurance | #1250182 |
| August 30, 2024 | Alcon Research LLC | Not classified | Drug Quality Assurance | #1230060 |
Documents (87)
- 483 · RC Outsourcing, LLC · August 28, 2025
- 483 · Unknown Company · July 28, 2014
- 483 · AIRGAS USA, LLC. · November 4, 2021
- 483 · QuVa Pharma, Inc. · March 14, 2019
- 483 · Flourish Integrative Pharmacy, LLC · December 19, 2018
- 483 · Carie Boyd Pharmaceuticals LLC · June 27, 2022
- 483 · Qualgen, LLC · September 30, 2022
- 483 · Qualgen LLC · June 15, 2021
- 483 · CFP Acquisitions Inc. · January 18, 2022
- 483 · OurPharma LLC · September 30, 2021
- 483 · MCALISTER DRUG CORPORATION · October 3, 2019
- 483 · SCA Pharmaceuticals, Inc. · May 17, 2023
- 483 · Lowlyn Pharmacies, Inc. · March 8, 2013
- 483 · Specialty Compounding, LLC · September 13, 2013
- 483 · Peoples Pharmacy, Inc. · December 7, 2017
- 483 · CFP Acquisitions Inc. · July 23, 2015
- 483 · Medcraft LLC · July 27, 2018
- 483 · Carie Boyd Pharmaceuticals LLC · December 12, 2014
- 483 · Stonegate Pharmacy LP · March 2, 2016
- 483 · Qualgen, LLC · May 10, 2017
- 483 · Physician Preferred Medical, LLC · February 19, 2015
- 483 · ICU Medical Inc · August 24, 2012
- 483 · OurPharma LLC · September 27, 2024
- 483 · Delta Pharma, Inc. · April 12, 2024
- 483 · Mixlab TX LLC · August 2, 2024
- 483 · CFP Acquisitions Inc. · July 11, 2018
- 483 · Specialty Compounding, LLC · March 22, 2013
- 483 · Empower Pharmacy · August 5, 2022
- 483 · ARL Biopharma, Inc. · November 8, 2012
- 483 · Qualgen, LLC · March 19, 2024
- 483 · Humco Holding Group, Inc. · March 13, 2020
- 483 · Qualgen, LLC · September 17, 2015
- EIR · Oklahoma Blood Institute - IRB · February 27, 2006
- 483 · Denver Solutions, LLC DBA Leiters Health · November 13, 2025
- 483 · Petscript Inc · September 8, 2025
- EIR · Mission Pharmacal Company · April 4, 2016
- 483 · 3D Imaging Drug Design and Development · June 9, 2025
- 483 · Southern Spectrographic Laboratory, Inc. · May 11, 2024
- 483 · Qualgen LLC · September 13, 2018
- 483 · Alcon Research LLC · August 30, 2024
- 483 · Petscript Inc. · September 18, 2025
- 483 · Cambrex Profarmaco Milano Srl · May 15, 2017
- 483 · Mission Pharmacal Company · April 4, 2019
- 483 · Encore Scientific LLC · June 13, 2019
- 483 · BioMed Laboratories, LLC. · October 31, 2025
- 483 · Compounders International Analytical Laboratory · March 5, 2025
- 483 · Deepwater Chemicals, Inc · February 14, 2025
- 483 · Sovereign Pharmaceuticals, LLC · May 12, 2025
- 483 · Dhaliwal Laboratories LLC · June 26, 2025
- 483 · Sandoz GmbH · September 10, 2018
- 483 · Cytovance Biologics Inc. · September 19, 2018
- 483 · LIFECYCLE BIOTECHNOLOGIES, LP · June 23, 2023
- 483 · University of Texas Southwestern Medical Center, The · September 9, 2019
- 483 · Cosmetic Specialty Labs, Inc · September 22, 2010
- 483 · Sovereign Pharmaceuticals, LLC · August 2, 2023
- 483 · Ionetix Corporation · September 14, 2023
- EIR · Allergan Sales, LLC · March 25, 2011
- 483 · PETNET SOLUTIONS, INC. · February 15, 2023
- 483 · Pharma Nobis LLC · March 13, 2020
- 483 · CareFusion 213, LLC · September 29, 2023
- 483 · PD-Rx Pharmaceuticals, Inc. · November 10, 2022
- 483 · ARL Biopharma, Inc. · September 5, 2019
- EIR · Midwest Medical Isotopes LLC · August 13, 2014
- EIR · Sterigenics Belgium (Fleurus) S.A. · May 24, 2017
- 483 · Swiss American CDMO, LLC · September 4, 2008
- 483 · Nephron Sterile Compounding Center LLC · April 20, 2022
- 483 · 3D Imaging Drug Design and Development · June 13, 2025
- 483 · Haupt Pharma Wolfratshausen GmbH · November 12, 2011
- 483 · Oklahoma Blood Institute - IRB · February 27, 2006
- 483 · Analytical Food Laboratories Inc. · May 17, 2024
- 483 · Alcon Research LLC · August 4, 2017
- 483 · Fresenius USA Manufacturing, Inc · June 22, 2020
- 483 · Nephron Sc Inc · April 20, 2022
- 483 · Claremore Compounding Center, Inc. · January 24, 2020
- 483 · Neos Therapeutics, LP · August 25, 2023
- 483 · Kyowa Hakko Bio Co., Ltd. · November 8, 2019
- 483 · CFP Acquisitions Inc. · December 8, 2022
- 483 · Kalchem International, Inc. · February 21, 2020
- 483 · Eosera, Inc. · March 20, 2026
- 483 · Chromatography Institute of America, Inc. · May 5, 2023
- 483 · Family Dollar Distribution Inc. · February 11, 2022
- 483 · AURORIUM LLC · March 2, 2026
- 483 · Cytovance Biologics Inc. · June 8, 2026
- 483 · Antaria Pty., Ltd. · November 13, 2023
- 483 · Houston Rx LLC · August 28, 2026
- 483 · Allergan Sales, LLC · July 31, 2026
- 483 · Veterinary Enterprises of Tomorrow Inc. · June 3, 2026
Frequently inspected with (10)
Oluwasefunm Agbanigo
5 shared
Megan T. Ziegler
CSO
4 shared
Shanna N. Purdy
Investigator
4 shared
Rodney L. Tinzie
3 shared
Shawn E. Larson
Development Coordinator
3 shared
Aqualia L. Nelson
Strategic Accounts Operations Manager / Account Executive
2 shared
Dorothy P. Kramer
2 shared
Kevin T. Nguyen
investigator
2 shared
Milton J. De Jesus Tavarez
2 shared
Ronda R. Lloyd-Jones
Director of Compliance Branch
2 shared
Person Information
Name
Margaret M. Annes
Role
Regulatory Personnel
ID: e528fbbe-2a4c-4697-9256-b7f2d0bcd279
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.